Anxo Pharmaceutical , Ltd. Profit Margin

Anxo Pharmaceutical , Ltd. (6677.TWO) currently reports a profit margin of -3.56% as of June 2026. That compares with 0.73% in the prior-year period — down 588.9% year over year. That is below the sector sector average of 13.2%. Use the charts on this page to explore Anxo Pharmaceutical , Ltd.'s profit margin history and peer comparisons.

Anxo Pharmaceutical , Ltd.'s profit margin decreased from 0.73% to -3.56% — a 588.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anxo Pharmaceutical , Ltd.'s profit margin of -3.56% is lower than the its sector sector average of 13.2%. That is roughly 127.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Anxo Pharmaceutical , Ltd.'s current -3.56% should be judged against industry norms (sector average: 13.2%) and against 6677.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -3.56%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.2%. From there, open related valuation or income-statement pages for Anxo Pharmaceutical , Ltd., and consider following 6677.TWO for alerts when major investors trade the stock.